MAPS has recently completed the first double-blind, placebo-controlled study of the therapeutic use of LSD in human beings since the early 1970s.
LSD (lysergic acid diethylamide) is a semi-synthetic compound first developed in 1938 by Dr. Albert Hofmann at the Sandoz pharmaceutical company in Basel, Switzerland. After Dr. Hofmann first discovered its effects in 1943, LSD quickly became recognized for its possible therapeutic effects. LSD also played a significant role in the discovery of the serotonin neurotransmitter system.
Our recently completed Phase 2 pilot study in 12 [...]
When 65 year-old psychotherapist Estalyn Walcoff was diagnosed with a type of untreatable lymphoma 5 years ago, she could barely handle the news.
She explains (seen in the video below), that the prognosis only perpetuated her already present anxiety, something she’d faced throughout her life.
But Estalyn was determined to stay positive, repeating positive affirmations such as “even though no one else has made it, it’s possible that I can.“
Another shift came with Estalyn’s new-found desire to look inwards, to discover who she really was. She knew she didn’t want a bitter heart, and she became curious if incorporating a spiritual outlook into her life would help [...]